PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,000 | -22.2% | 2,002 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -5.3% | 2,002 | 0.0% | 0.00% | – |
| Q1 2021 | $19,000 | -5.0% | 2,002 | 0.0% | 0.00% | – |
| Q4 2020 | $20,000 | 0.0% | 2,002 | 0.0% | 0.00% | – |
| Q3 2020 | $20,000 | -4.8% | 2,002 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | +23.5% | 2,002 | 0.0% | 0.00% | – |
| Q1 2020 | $17,000 | 0.0% | 2,002 | 0.0% | 0.00% | – |
| Q4 2019 | $17,000 | -64.6% | 2,002 | -47.0% | 0.00% | – |
| Q2 2019 | $48,000 | -67.1% | 3,774 | 0.0% | 0.00% | – |
| Q1 2019 | $146,000 | +97.3% | 3,774 | 0.0% | 0.00% | – |
| Q4 2018 | $74,000 | -57.2% | 3,774 | 0.0% | 0.00% | – |
| Q3 2018 | $173,000 | -22.4% | 3,774 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $223,000 | -13.2% | 3,774 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $257,000 | -30.9% | 3,774 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $372,000 | +5.7% | 3,774 | +25.4% | 0.00% | 0.0% |
| Q3 2017 | $352,000 | +34.4% | 3,009 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $262,000 | +133.9% | 3,009 | 0.0% | 0.00% | – |
| Q1 2017 | $112,000 | +20.4% | 3,009 | 0.0% | 0.00% | – |
| Q4 2016 | $93,000 | -76.9% | 3,009 | -50.0% | 0.00% | -100.0% |
| Q3 2016 | $402,000 | +351.7% | 6,018 | +100.0% | 0.00% | – |
| Q2 2016 | $89,000 | +1.1% | 3,009 | 0.0% | 0.00% | – |
| Q1 2016 | $88,000 | -62.7% | 3,009 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $236,000 | -45.4% | 3,009 | -47.5% | 0.00% | -50.0% |
| Q3 2015 | $432,000 | +1.6% | 5,728 | +56.8% | 0.00% | +100.0% |
| Q2 2015 | $425,000 | -13.4% | 3,652 | +74.9% | 0.00% | -50.0% |
| Q1 2015 | $491,000 | +24.6% | 2,088 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $394,000 | -21.2% | 2,088 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $500,000 | +327.4% | 2,088 | +17.8% | 0.00% | – |
| Q2 2014 | $117,000 | – | 1,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |